Last reviewed · How we verify

cephalosporin with or without erythromycin

Universidad de Granada · Phase 1 active Small molecule

cephalosporin with or without erythromycin is a Small molecule drug developed by Universidad de Granada. It is currently in Phase 1 development. Also known as: Standard medical treatment.

At a glance

Generic namecephalosporin with or without erythromycin
Also known asStandard medical treatment
SponsorUniversidad de Granada
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about cephalosporin with or without erythromycin

What is cephalosporin with or without erythromycin?

cephalosporin with or without erythromycin is a Small molecule drug developed by Universidad de Granada.

Who makes cephalosporin with or without erythromycin?

cephalosporin with or without erythromycin is developed by Universidad de Granada (see full Universidad de Granada pipeline at /company/universidad-de-granada).

Is cephalosporin with or without erythromycin also known as anything else?

cephalosporin with or without erythromycin is also known as Standard medical treatment.

What development phase is cephalosporin with or without erythromycin in?

cephalosporin with or without erythromycin is in Phase 1.

Related